Azelis Group NV | Large-cap | Basic Materials

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 5.8B
Total Liabilities 2.8B
Shareholders Equity 2.9B
Debt to Equity 0.97

Cash Flow Metrics

Revenue & Profitability Trend

Azelis Group NV Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i4.2B4.2B4.1B2.8B2.2B
Cost of Goods Sold i3.2B3.2B3.2B2.2B1.7B
Gross Profit i1.0B984.1M960.7M650.1M479.5M
Gross Margin % i24.3%23.6%23.3%22.9%21.6%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i175.0M166.8M158.8M117.3M91.6M
Other Operating Expenses i38.8M25.1M41.9M30.6M17.1M
Total Operating Expenses i213.8M191.9M200.7M147.9M108.8M
Operating Income i385.9M386.9M388.4M207.8M147.2M
Operating Margin % i9.1%9.3%9.4%7.3%6.6%
Non-Operating Items
Interest Income i14.8M10.7M621.0K618.0K871.0K
Interest Expense i106.0M97.4M38.2M49.9M58.4M
Other Non-Operating Income-----
Pre-tax Income i256.1M247.2M314.7M120.2M79.1M
Income Tax i66.6M57.9M95.8M50.0M8.1M
Effective Tax Rate % i26.0%23.4%30.4%41.6%10.2%
Net Income i189.5M189.3M218.9M70.2M71.0M
Net Margin % i4.5%4.5%5.3%2.5%3.2%
Key Metrics
EBITDA i471.3M466.9M457.8M229.5M188.4M
EPS (Basic) i€0.74€0.74€0.91€0.29€0.30
EPS (Diluted) i€0.74€0.74€0.91€0.29€0.30
Basic Shares Outstanding i244179730240140541233750000233846000233846153
Diluted Shares Outstanding i244179730240140541233750000233846000233846153

Income Statement Trend

Azelis Group NV Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i303.9M484.9M268.2M141.3M163.3M
Short-term Investments i604.0K60.0K280.0K1.5M238.0K
Accounts Receivable i496.4M444.9M443.3M429.0M218.7M
Inventory i677.9M562.8M627.7M467.5M267.8M
Other Current Assets-1.0K-1.0K-1.0K--
Total Current Assets i1.6B1.6B1.4B1.0B691.9M
Non-Current Assets
Property, Plant & Equipment i103.9M88.1M58.0M118.6M30.9M
Goodwill i6.5B6.2B5.5B4.6B3.5B
Intangible Assets i1.4B1.3B1.2B1.0B821.4M
Long-term Investments-----
Other Non-Current Assets-1.0K-3.0K-2.0K--
Total Non-Current Assets i4.2B4.0B3.5B2.9B2.3B
Total Assets i5.8B5.6B5.0B4.0B3.0B
Liabilities
Current Liabilities
Accounts Payable i486.8M434.1M462.7M368.7M237.0M
Short-term Debt i95.6M125.1M176.1M118.3M101.6M
Current Portion of Long-term Debt-----
Other Current Liabilities-----1.0K
Total Current Liabilities i818.9M939.8M975.3M678.4M417.1M
Non-Current Liabilities
Long-term Debt i1.7B1.7B1.3B894.1M1.2B
Deferred Tax Liabilities i225.9M218.3M190.8M135.3M110.0M
Other Non-Current Liabilities---9.7M7.9M
Total Non-Current Liabilities i2.0B2.0B1.6B1.1B1.3B
Total Liabilities i2.8B2.9B2.5B1.7B1.7B
Equity
Common Stock i5.9B5.9B5.7B5.7B11.8M
Retained Earnings i876.3M637.1M405.8M164.6M95.6M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i2.9B2.7B2.4B2.3B1.2B
Key Metrics
Total Debt i1.8B1.8B1.4B1.0B1.3B
Working Capital i764.0M653.7M469.2M365.2M274.8M

Balance Sheet Composition

Azelis Group NV Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i189.5M189.3M218.9M70.2M71.0M
Depreciation & Amortization i-----
Stock-Based Compensation i1.3M1.4M839.0K0-
Working Capital Changes i-153.3M203.0M-38.6M-149.3M5.4M
Operating Cash Flow i183.0M525.6M255.0M16.9M144.5M
Investing Activities
Capital Expenditures i-13.9M-15.5M-18.4M-18.3M-12.1M
Acquisitions i-241.5M-584.6M-553.7M-633.9M-103.3M
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-255.3M-600.1M-572.1M-652.2M-115.4M
Financing Activities
Share Repurchases i-2.5M-3.4M-3.0M0-
Dividends Paid i-53.3M-67.8M-7.0M--
Debt Issuance i1.3B768.1M640.6M909.7M78.3M
Debt Repayment i-1.2B-453.4M-217.4M-1.2B0
Financing Cash Flow i-73.5M443.3M407.2M608.3M78.3M
Free Cash Flow i309.1M509.6M350.8M143.6M104.9M
Net Change in Cash i-145.8M368.9M90.1M-27.0M107.5M

Cash Flow Trend

Azelis Group NV Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 17.67
Forward P/E 10.60
Price to Book 1.12
Price to Sales 0.70
PEG Ratio 10.60

Profitability Ratios

Profit Margin 4.01%
Operating Margin 8.89%
Return on Equity 6.41%
Return on Assets 3.98%

Financial Health

Current Ratio 1.68
Debt to Equity 77.22
Beta 0.54

Per Share Data

EPS (TTM) €0.69
Book Value per Share €10.90
Revenue per Share €17.36

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
aze3.1B17.671.126.41%4.01%77.22
Syneos Health 7.4B377.861.19-1.20%-1.30%45.57
Solvay SA 2.9B20.702.4911.13%2.81%185.12
Titan Cement 2.7B13.111.5112.28%7.88%36.26
Solvac S.A 1.9B18.450.774.16%2,518,580.00%5.96
Tessenderlo Group NV 1.5B37.210.86-1.40%-0.99%14.34

Financial data is updated regularly. All figures are in the company's reporting currency.